NASDAQ
5.85USD
+0.09 (+1.56%)
We have scored 3 news catalysts on eXoZymes, Inc. (EXOZ) over the past 12 months. The biggest single-day move next to one of them came Jun 8, 2026, when EXOZ closed −7.7%: “eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants”. Coverage across the window leans positive (average ticker sentiment +0.23). Most of the impact sits in price momentum and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
54.3M
P/E
—
EPS
—
Beta
3.15
52W range
4.35-18.4
Day range
5.83–6.14
Open
6.12
Prev close
5.76
Volume
908.6
Avg volume
8.8K
Dividend
0.00
IPO
2024-11-13
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about eXoZymes, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for EXOZ: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
